These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16751605)

  • 1. The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.
    McLaughlin RW; De Stigter JK; Sikkink LA; Baden EM; Ramirez-Alvarado M
    Protein Sci; 2006 Jul; 15(7):1710-22. PubMed ID: 16751605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans.
    Blancas-Mejía LM; Hammernik J; Marin-Argany M; Ramirez-Alvarado M
    J Biol Chem; 2015 Feb; 290(8):4953-4965. PubMed ID: 25538238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation.
    Castillo GM; Lukito W; Wight TN; Snow AD
    J Neurochem; 1999 Apr; 72(4):1681-7. PubMed ID: 10098877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific glycosaminoglycans promote unseeded amyloid formation from beta2-microglobulin under physiological conditions.
    Borysik AJ; Morten IJ; Radford SE; Hewitt EW
    Kidney Int; 2007 Jul; 72(2):174-81. PubMed ID: 17495865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions.
    Fraser PE; Nguyen JT; Chin DT; Kirschner DA
    J Neurochem; 1992 Oct; 59(4):1531-40. PubMed ID: 1402902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of the integral glycosaminoglycan constituents of human amyloid A and monoclonal light-chain amyloid fibrils.
    Nelson SR; Lyon M; Gallagher JT; Johnson EA; Pepys MB
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):67-73. PubMed ID: 1902087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between glycosaminoglycans and immunoglobulin light chains.
    Jiang X; Myatt E; Lykos P; Stevens FJ
    Biochemistry; 1997 Oct; 36(43):13187-94. PubMed ID: 9341206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
    Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
    Elife; 2020 Mar; 9():. PubMed ID: 32151314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.
    Blancas-Mejía LM; Misra P; Ramirez-Alvarado M
    Biochemistry; 2017 Feb; 56(5):757-766. PubMed ID: 28074646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salts enhance both protein stability and amyloid formation of an immunoglobulin light chain.
    Sikkink LA; Ramirez-Alvarado M
    Biophys Chem; 2008 Jun; 135(1-3):25-31. PubMed ID: 18395318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin light chains, glycosaminoglycans, and amyloid.
    Stevens FJ; Kisilevsky R
    Cell Mol Life Sci; 2000 Mar; 57(3):441-9. PubMed ID: 10823245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils.
    Ren R; Hong Z; Gong H; Laporte K; Skinner M; Seldin DC; Costello CE; Connors LH; Trinkaus-Randall V
    J Biol Chem; 2010 Nov; 285(48):37672-82. PubMed ID: 20870723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity.
    Blancas-Mejía LM; Ramirez-Alvarado M
    Biochemistry; 2016 May; 55(21):2967-78. PubMed ID: 27158939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation.
    Kim YS; Randolph TW; Manning MC; Stevens FJ; Carpenter JF
    J Biol Chem; 2003 Mar; 278(12):10842-50. PubMed ID: 12529361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin light chain amyloid aggregation.
    Blancas-Mejia LM; Misra P; Dick CJ; Cooper SA; Redhage KR; Bergman MR; Jordan TL; Maar K; Ramirez-Alvarado M
    Chem Commun (Camb); 2018 Sep; 54(76):10664-10674. PubMed ID: 30087961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis.
    Brumshtein B; Esswein SR; Sawaya MR; Rosenberg G; Ly AT; Landau M; Eisenberg DS
    J Biol Chem; 2018 Dec; 293(51):19659-19671. PubMed ID: 30355736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of glycosaminoglycans with DNA and RNA synthesizing enzymes in vitro.
    Schaffrath D; Stuhlsatz HW; Greiling H
    Hoppe Seylers Z Physiol Chem; 1976 Apr; 357(4):499-508. PubMed ID: 61158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycans enhance the fibrillation propensity of the β2-microglobulin cleavage variant--ΔK58-β2m.
    Corlin DB; Johnsen CK; Nissen MH; Heegaard NH
    Biochem Biophys Res Commun; 2010 Nov; 402(2):247-51. PubMed ID: 20939999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-state NMR chemical shift assignments for AL-09 V
    Piehl DW; Blancas-Mejía LM; Ramirez-Alvarado M; Rienstra CM
    Biomol NMR Assign; 2017 Apr; 11(1):45-50. PubMed ID: 27771830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.